This article seeks to promote dialogue among stakeholders to facilitate consensus regarding requirements for excipients.
Phyllis Walsh
Advertisement
Phyllis Walsh is a senior compendial manager at Schering-Plough Corporation in Kenilworth, New Jersey.
Articles by Phyllis Walsh
Current guidance for absorption of elemental impurities does not address dermal exposure, resulting in a simplistic approach to limit setting.
Advertisement
Latest Updated Articles
Establishing Limits for Dermal Absorption of Elemental ImpuritiesPublished: September 2nd 2015 | Updated:
The Real Complexity of Excipient CompositionPublished: October 2nd 2017 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Using AI and Molecular Dynamics to Overcome the Poor Solubility Challenge
2
Why Context Matters in Validating Biomarker Assays for Bioanalysis
3
Targeted high resolution metabolite screening workflows
4
Application of alternative electron-based fragmentation for identification of drug metabolites and quantification of complex peptide therapeutics
5
